Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TXNIP: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
TXNIP is a gene implicated in neurodegeneration research. Key relationships include: activates, therapeutic target, inhibits. Associated with Als, Atherosclerosis, Diabetes. Connected to 65 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | TXNIP |
| Chromosome | 1q21.1 |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Primary Expression | virtually all tissues, with particularly high expression in brain (especially hippocampus, hypothalamus, and cortex), he |
| Molecular Weight | 46 kDa |
| Amino Acids | 397 aa |
| Exons | 9 |
| Pathways | Amyloid, Er Stress, Inflammasome, Nf-Κb |
| NCBI Gene ID | 10628 |
| GeneCards | TXNIP |
| Human Protein Atlas | TXNIP |
| Associated Diseases | neuroinflammation |
| Interactions | Actin, AMPK, AND, APAF1, APOPTOSIS, ASC |
| KG Connections | 258 knowledge graph edges |
| Databases | GeneCardsUniProtHPASTRING |
Knowledge base pages for this entity
graph TD
TXNIP["TXNIP"]
PRKAA["PRKAA"]
TXNIP -->|"interacts with"| PRKAA
TXNIP -->|"regulates"| PRKAA
autophagy(["autophagy"])
TXNIP -->|"activates"| autophagy
fatty_acid_oxidation(["fatty acid oxidation"])
TXNIP -->|"activates"| fatty_acid_oxidation
steatohepatitis{"steatohepatitis"}
TXNIP -->|"protects against"| steatohepatitis
Atherosclerosis{"Atherosclerosis"}
TXNIP -->|"activates"| Atherosclerosis
Stroke{"Stroke"}
TXNIP -->|"activates"| Stroke
Hepatitis{"Hepatitis"}
TXNIP -->|"inhibits"| Hepatitis
Diabetes{"Diabetes"}
TXNIP -->|"therapeutic target"| Diabetes
Fibrosis{"Fibrosis"}
TXNIP -->|"activates"| Fibrosis
Inflammation{"Inflammation"}
TXNIP -->|"activates"| Inflammation
Neuroinflammation{"Neuroinflammation"}
TXNIP -->|"activates"| Neuroinflammation
SQSTM1["SQSTM1"]
SQSTM1 -->|"activates"| TXNIP
LC3B["LC3B"]
LC3B -->|"activates"| TXNIP
P62["P62"]
P62 -->|"activates"| TXNIP
MAP1LC3B["MAP1LC3B"]
MAP1LC3B -->|"activates"| TXNIP
MTOR["MTOR"]
MTOR -->|"therapeutic target"| TXNIP
STING["STING"]
STING -->|"activates"| TXNIP
GENES["GENES"]
GENES -->|"activates"| TXNIP
NRF2["NRF2"]
NRF2 -->|"activates"| TXNIP
CYLD["CYLD"]
CYLD -->|"activates"| TXNIP
APAF1["APAF1"]
APAF1 -->|"activates"| TXNIP
MTORC1["MTORC1"]
MTORC1 -->|"activates"| TXNIP
MICROGLIA["MICROGLIA"]
MICROGLIA -->|"activates"| TXNIP
style TXNIP fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| PRKAA | interacts_with | protein | 0.90 |
| PRKAA | regulates | protein | 0.90 |
| NLRP3 | interacts_with | gene | 0.90 |
| steatohepatitis | protects_against | disease | 0.90 |
| autophagy | activates | pathway | 0.90 |
| fatty acid oxidation | activates | pathway | 0.90 |
| Inflammasome | activates | pathway | 0.70 |
| Diabetes | therapeutic_target | disease | 0.65 |
| Fibrosis | activates | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| Ms | protects_against | disease | 0.65 |
| Atherosclerosis | activates | disease | 0.65 |
| Stroke | protects_against | disease | 0.65 |
| Alzheimer | protects_against | disease | 0.65 |
| Parkinson | interacts_with | disease | 0.65 |
| Inflammation | interacts_with | disease | 0.65 |
| Parkinson | protects_against | disease | 0.65 |
| Hepatitis | inhibits | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Ischemia | inhibits | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Lymphoma | biomarker_for | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Ischemia | regulates | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Ferroptosis | regulates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Diabetes | contributes_to | disease | 0.65 |
| Stroke | inhibits | disease | 0.65 |
| Pyroptosis | inhibits | disease | 0.65 |
| Dementia | inhibits | disease | 0.65 |
| Neuroinflammation | inhibits | disease | 0.65 |
| Necroptosis | inhibits | disease | 0.65 |
| Caspase | inhibits | protein | 0.60 |
| IL-1 | activates | gene | 0.60 |
| Oxidative Stress | inhibits | pathway | 0.60 |
| Actin | activates | protein | 0.60 |
| Caspase | activates | protein | 0.60 |
| SQSTM1 | activates | gene | 0.60 |
| MAP1LC3B | activates | gene | 0.60 |
| NLRP3 | associated_with | gene | 0.60 |
| TLR4 | associated_with | gene | 0.60 |
| AKT | associated_with | gene | 0.60 |
| PI3K | associated_with | gene | 0.60 |
| RB1 | protects_against | gene | 0.60 |
| NRF2 | associated_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ZFP36 | downregulates | gene | 0.95 |
| ZFP36 | binds | gene | 0.95 |
| ROS | activates | gene | 0.80 |
| NPAS3 | regulates | gene | 0.80 |
| ROS | regulates | gene | 0.70 |
| ASC | expressed_in | gene | 0.60 |
| GSDMD | activates | gene | 0.60 |
| NLRP3 | associated_with | gene | 0.60 |
| PI3K | associated_with | gene | 0.60 |
| TLR4 | associated_with | gene | 0.60 |
| ATP13A2 | regulates | gene | 0.60 |
| ZFP36 | inhibits | gene | 0.60 |
| OXIDATIVE STRESS | activates | gene | 0.60 |
| DIABETES MELLITUS | therapeutic_target | gene | 0.60 |
| AUTOPHAGY | therapeutic_target | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 0.60 |
| NF-ΚB | associated_with | gene | 0.60 |
| PARKINSON | protects_against | gene | 0.60 |
| HO-1 | associated_with | gene | 0.60 |
| WNT | associated_with | gene | 0.60 |
| MYH9 | activates | gene | 0.60 |
| HUB GENES | regulates | gene | 0.60 |
| AMYLOID | regulates | gene | 0.60 |
| MIRNAS | activates | gene | 0.60 |
| MICRORNAS | regulates | gene | 0.60 |
| MIR-155 | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| ALZHEIMER'S DISEASE | regulates | gene | 0.60 |
| CCND1 | activates | gene | 0.60 |
| BAK | inhibits | gene | 0.60 |
| AMPK | activates | gene | 0.60 |
| BAK | activates | gene | 0.60 |
| TLR | regulates | gene | 0.60 |
| MTOR | therapeutic_target | gene | 0.60 |
| STING | activates | gene | 0.60 |
| NRF2 | activates | gene | 0.60 |
| CYLD | activates | gene | 0.60 |
| TLR4 | activates | gene | 0.60 |
| APAF1 | activates | gene | 0.60 |
| IL7R | inhibits | gene | 0.60 |
| TBP | activates | gene | 0.60 |
| INFLAMMATION | interacts_with | gene | 0.60 |
| AXIN1 | activates | gene | 0.60 |
| STAT3 | activates | gene | 0.60 |
| RHEB | activates | gene | 0.60 |
| EGR1 | activates | gene | 0.60 |
| HNF4A | activates | gene | 0.60 |
| MYC | activates | gene | 0.60 |
| YWHAZ | activates | gene | 0.60 |
| LC3B | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning TXNIP in their description or question text
No additional research found